Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010
- PMID: 23171644
- PMCID: PMC3557896
- DOI: 10.3201/eid1812.120638
Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010
Abstract
The US Public Health Emergency Medical Countermeasures Enterprise convened subject matter experts at the 2010 HHS Burkholderia Workshop to develop consensus recommendations for postexposure prophylaxis against and treatment for Burkholderia pseudomallei and B. mallei infections, which cause melioidosis and glanders, respectively. Drugs recommended by consensus of the participants are ceftazidime or meropenem for initial intensive therapy, and trimethoprim/sulfamethoxazole or amoxicillin/clavulanic acid for eradication therapy. For postexposure prophylaxis, recommended drugs are trimethoprim/sulfamethoxazole or co-amoxiclav. To improve the timely diagnosis of melioidosis and glanders, further development and wide distribution of rapid diagnostic assays were also recommended. Standardized animal models and B. pseudomallei strains are needed for further development of therapeutic options. Training for laboratory technicians and physicians would facilitate better diagnosis and treatment options.
Similar articles
-
Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.Int J Antimicrob Agents. 2013 Jun;41(6):552-7. doi: 10.1016/j.ijantimicag.2013.02.007. Epub 2013 Mar 19. Int J Antimicrob Agents. 2013. PMID: 23517714
-
Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):233-41. doi: 10.2174/157489107782497335. Recent Pat Antiinfect Drug Discov. 2007. PMID: 18221181 Review.
-
Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.PLoS One. 2015 Jul 6;10(7):e0132032. doi: 10.1371/journal.pone.0132032. eCollection 2015. PLoS One. 2015. PMID: 26148026 Free PMC article.
-
Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.Mil Med. 2009 Jun;174(6):647-51. Mil Med. 2009. PMID: 19585782 Review.
-
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.Vaccine. 2009 Jul 16;27(33):4447-51. doi: 10.1016/j.vaccine.2009.05.040. Epub 2009 May 31. Vaccine. 2009. PMID: 19490962
Cited by
-
Genome Sequence of the Historical Clinical Isolate Burkholderia pseudomallei PHLS 6.Genome Announc. 2016 Jun 30;4(3):e00649-16. doi: 10.1128/genomeA.00649-16. Genome Announc. 2016. PMID: 27365360 Free PMC article.
-
Clinical repercussions of Glanders (Burkholderia mallei infection) in a Brazilian child: a case report.Rev Soc Bras Med Trop. 2020 Jun 22;53:e20200054. doi: 10.1590/0037-8682-0054-2020. eCollection 2020. Rev Soc Bras Med Trop. 2020. PMID: 32578712 Free PMC article.
-
Evaluation of the Active Melioidosis Detect™ test as a point-of-care tool for the early diagnosis of melioidosis: a comparison with culture in Laos.Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):757-763. doi: 10.1093/trstmh/trz092. Trans R Soc Trop Med Hyg. 2019. PMID: 31638152 Free PMC article.
-
Postexposure Antimicrobial Drug Therapy in Goats Infected with Burkholderia pseudomallei.Emerg Infect Dis. 2025 May;31(5):967-975. doi: 10.3201/eid3105.241274. Emerg Infect Dis. 2025. PMID: 40305354 Free PMC article.
-
Preparing for biological threats: Addressing the needs of pregnant women.Birth Defects Res. 2017 Mar 15;109(5):391-398. doi: 10.1002/bdr2.1016. Birth Defects Res. 2017. PMID: 28398677 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical